EUCAST News
Here you can find the latest news and updates from EUCAST.
EUCAST QC Table v 4.0 published
Information 2014-09-05: TheEUCAST QC table v 4.0 (2014-09-05) - the most important changes and additions are: - MIC ranges for amoxicillin-clavulanic acid and ampicillin-sulbactam validated for testing with fixed...[more]
Compliance of manufacturers - update
"Compliance of manufacturers of AST devices and materials with EUCAST guidelines" was updated 15 August, 2014. Major changes are related to Bioanalyse added as disk manufacturers, Vitek2 (bioMérieux) updated,...[more]
Breakpoints for antifungal agents v 7.0 published
The updated breakpoint table for antifungal agents was published on 12 August, 2014.[more]
EUCAST Consultation on the revision of ciprofloxacin breakpoints for N.meningitidis.
EUCAST breakpoints for Neisseria meningitidis currently include an intermediate category for ciprofloxacin (Susceptible ≤0.03 mg/L, Intermediate 0.06 mg/L, Resistant >0.06 mg/L). When breakpoints were originally set...[more]
EUCAST Consultation on the reporting of dissociated clindamicin resistance.
Open consultation on the EUCAST recommendation for reporting susceptibility of staphylococci and streptococci with dissociated resistance to clindamycin. Deadline for responding is 12 September, 2014. Please use the consultation...[more]
Morocco has joined EUCAST and formed a NAC!
Morocco has joined the EUCAST General Committee (representative Prof Amina Benaouda)and formed a NAC. A website is available. Read more about Morocco and aboutNACs.<//span>[more]
Itraconazole vs. Candida spp v 1.0 published
The rationale document "Itraconazole vs. Candida spp v 1.0" is published along with comments and replies from the consultation process.[more]
